ALA derivatives - PhotoCure

Drug Profile

ALA derivatives - PhotoCure

Alternative Names: Aminolevulinate derivatives - PhotoCure

Latest Information Update: 17 Feb 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PhotoCure
  • Developer Photocure
  • Class Amino acids; Keto acids; Levulinic acids; Small molecules
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Brain cancer; Breast cancer; Colorectal cancer; Gynaecological cancer; Head and neck cancer; High-grade oesophageal dysplasia

Most Recent Events

  • 29 Apr 2005 Discontinued - Phase-I for Head and neck cancer in Norway (unspecified route)
  • 29 Apr 2005 Discontinued - Phase-I for High-grade oesophageal dysplasia in Norway (unspecified route)
  • 15 Apr 2003 Phase-I clinical trials in Gynaecological cancer in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top